GU
Yale Cancer Center
Key Advances in Prostate Cancer in 2025: Transforming Imaging With PSMA PET
FEATURING
William Oh
- 46 views
- March 17, 2025
Yale Cancer Center
Key Advances in Prostate Cancer in 2025: The Next Era of Targeted Therapy - Radioligands, Bispecifics, and Beyond
FEATURING
William Oh
- 41 views
- March 17, 2025
Yale Cancer Center
Key Advances in Prostate Cancer in 2025: Molecular Biomarkers and PARPi
FEATURING
William Oh
- 14 views
- March 13, 2025
Yale Cancer Center
Key Advances in Prostate Cancer in 2025: Androgen Receptor Pathway Inhibitors - The First Targeted Therapy
FEATURING
William Oh
- 10 views
- March 12, 2025
Yale Cancer Center
Key Advances in Prostate Cancer in 2025: Risk-Adapted Screening by Targeting High-Risk Populations
FEATURING
William Oh
- 16 views
- March 11, 2025
Yale Cancer Center
Microenvironmental Determinants of Systemic Therapy Response in Kidney Cancer: From Human to Mouse and Back
FEATURING
Ari Hakimi
- 15 views
- April 18, 2024
Yale Cancer Center
Determinants of Effective Anti-Tumor Immunity in Kidney Cancer
FEATURING
David Braun
- 192 views
- January 23, 2023
Yale Cancer Center
Can New Risk Assessment Tools for Prostate Cancer Deliver Better Patient Outcomes?
FEATURING
Michael Leapman
- 25 views
- August 19, 2022
Yale Cancer Center
Novel Insights in Obesity-Driven HCC
FEATURING
Carlos Fernandez-Hernando
- 20 views
- August 19, 2022
Yale Cancer Center
Yale Cancer Center Updates on mCRPC: New Data on Sequencing Multiple Agents
FEATURING
Daniel Petrylak
- 313 views
- July 23, 2021
- 3
Yale Cancer Center
Prostate Cancer and the Bending of the Cost Curve
FEATURING
James Yu
- 604 views
- December 27, 2018
- 2